Pharma & Biotech

The independent journey of CureVac as a publicly traded company has reached its conclusion. The Tübingen-based vaccine developer is now...

The equity of InnoCan Pharma continues to experience significant downward momentum. Closing at EUR 4.52 in the previous session, the...

In a strategic maneuver aimed at enhancing its financial flexibility, biotechnology firm Inmune Bio has modified the terms for a...

Shares of Viking Therapeutics gained approximately 2.9% to $36.42 following a pivotal regulatory decision that is reshaping the market for...

Pfizer shares enter the new week facing a complex set of signals. While the company is aggressively pursuing strategic growth...

Novo Nordisk finds itself navigating one of its most challenging periods in the stock market for years. The pharmaceutical company,...

Shares of medical device leader Abbott Laboratories opened the week on stable footing following a significant regulatory achievement. The company...

The pharmaceutical giant Pfizer is navigating a challenging start to 2026, caught in a crossfire of financial, regulatory, and competitive...

Intellia Therapeutics finds itself in a challenging phase as regulatory delays for a key drug candidate trigger a wave of...

Lexicon Pharmaceuticals finds itself at a pivotal juncture in its evolution into a research-driven biopharma entity. The company's near-term trajectory...